Semax for Sale: The Listing Is Not the Document

Summary: A listing can be neat, well photographed and entirely uninformative, so this page reads one line by line and then reads the certificate underneath it, including the places where that document contradicts itself.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

Every semax for sale page on the internet looks broadly the same: a clean product shot, a percentage, a badge or two, a price. The listing is the easiest part of a peptide business to make convincing, which is exactly why it is the wrong thing to judge one on.

The listing this page reads out loud is here, and its certificate is a click away, so you can check every claim below yourself.

What is in the vial, in one paragraph

Semax is a synthetic heptapeptide, seven residues in the order Met-Glu-His-Phe-Pro-Gly-Pro. The first four are the ACTH(4-7) fragment and the Pro-Gly-Pro tail is a stability modification that slows enzymatic breakdown. PubChem CID 9811102, formula C37H51N9O10S, molecular weight 813.9, CAS 80714-61-0 ^[4]. Developed and registered in Russia, approved by FDA for nothing.

If you are here from this site's GLP-1 coverage: it is not a GLP-1, not an incretin, has no effect on appetite or gastric emptying, and has no weight-management indication anywhere in the world. The evidence base is nothing like the one behind semaglutide or tirzepatide, and the English-language summaries of the Russian clinical work circulating online consistently overstate what that work supports.

Semax for sale: reading a listing field by field

A listing is a set of claims. Some of them can be checked before you pay, some can only be checked when the parcel opens, and some can never be checked at all. Sorting them that way is more useful than any trust badge.

The pattern in that table is worth naming. Almost every row where a listing can mislead you is a row where the listing is the only source. Every row where an outside document exists is a row where the seller has had to hand a piece of the argument to someone else. That is the whole game.

The document underneath, read past the summary page

The listing above links a four-part certificate for batch 30-05260628, report number KVR-2026-E848E0, issued by Kovera Labs ^[1]. Its first page is a summary and the three pages behind it are the analytical reports. Most readers stop at page one. The interesting reading is all behind it.

On the summary page: purity 99.886% against a printed reference standard of greater than 98%, net content 11.23 mg against a labelled 10 mg, identity confirmed as Semax by LC-MS, an endotoxin safety screen against a limit of 0.5 EU/mL marked pass, a microbial sterility screen marked no growth, and four heavy metals marked negative. The chromatogram is reproduced, with the method stated as RP-HPLC on a C18 column with diode array detection at 214 nm. It even records the physical description of the vial you should receive: red cap, silver crimp.

Two things about that summary are worth pausing on, and they point in opposite directions.

The good one: a stated specification sits beside almost every result. A purity number on its own is a decoration. A purity number printed next to the threshold it had to beat is a test with a pass condition, and the difference between those two things is most of what separates a real certificate from a designed one.

The less good one: "negative" is a compression. Turn to the elemental impurities page and the actual results appear, produced by ICP-MS with EPA-referenced methods: lead below 0.5 ppm against a limit of 10, arsenic below 0.15 against 1.5, cadmium below 0.05 against 0.5, mercury below 0.3 against 3. Spike recoveries run from 91% to 102% against a 70% to 150% criterion, which is the check that the method worked in this matrix at all. All of that is genuinely better than "negative", and all of it is invisible to anyone who reads only the front page.

The line on that certificate that contradicts itself

If a page is going to tell you to read a document rather than a summary, it should demonstrate what happens when you do.

The endotoxin report is headed as a kinetic chromogenic LAL assay performed in accordance with USP Chapter 85. Its own methodology table then lists the assay type as kinetic turbidimetric, with detection at 660 nm. Those are not the same method. A chromogenic assay reads colour development from a synthetic substrate, conventionally around 405 nm; a turbidimetric one reads increasing cloudiness, which is what a 660 nm reading describes.

To be clear about what this does and does not mean. Both are recognised compendial kinetic LAL methods, both are quantitative, and the reported result stands either way: endotoxin below 0.20 EU/mL against an acceptance limit of 0.5 EU/mL, using an E. coli O111:B4 standard over a 0.01 to 1.0 EU/mL detection range, positive and negative controls behaving as expected, final determination pass. This is a labelling inconsistency in the report, not a failed test.

It is still worth knowing, for two reasons. First, it is the sort of thing you can only find by reading, which is the habit this page is arguing for. Second, it gives you a specific question to put to the vendor rather than a vague suspicion, and the quality of the answer to a specific question tells you a great deal.

Two other details on that page belong in the same category. The sample CV, spike CV and spike recovery fields are all marked not applicable, which is consistent with a result reported below the quantitation threshold but means the inhibition and enhancement checks are not shown. And the sterility result is explicitly a rapid screen: two days of incubation at 30 to 35 degrees Celsius, no bacterial growth and no fungi or yeast detected, with the report itself noting that full USP Chapter 71 sterility testing may be required for regulatory compliance ^[1]. Printing your own caveat is a point in a laboratory's favour, and it is also a limit you should hold it to.

The certificate carries a report number and a per-page access code against a verification address at koveralabs.com/verify, which resolves. Whether entering the codes returns your document is worth two minutes of your own time before you rely on any of this.

What a thin certificate looks like, from the same vendor and the same round

The most instructive comparison available is the February 2026 round on the same storefront, which produced a thinner document for every compound including this one. The Selank certificate, for lot 29-01260229 from MZ Biolabs, reports purity 99.32% by HPLC-UV-MS with the chromatogram and peak list printed, and a measured 12.29 mg in a vial labelled 10 mg ^[2]. The February Semax certificate, lot 30-01260229 from the same laboratory, is built the same way. Both are real documents from a named laboratory at a checkable address, and publishing an assayed fill weight is unusual and creditable.

Neither carries an endotoxin test, an LAL result, a sterility screen or a metals panel. Not a failure, an absence. We went through the Selank one row by row in the Selank listing and the numbers it does report.

One storefront, two testing rounds, two levels of documentation, and both sit on product pages that look equally professional. Which one you get is a batch question rather than a product question, so read every certificate on the page rather than only the one that is a clickable link. That is the entire argument of this page, available to you in about a minute of clicking. The same divergence shows up on other compounds, and the way sellers describe what they have not tested is covered in what BPC-157 listings are really selling.

Why the missing tests are the ones that matter here

FDA has recorded one substantive concern about this compound. Compounded drugs containing semax "may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities", and the agency says it lacks sufficient information to know whether the drug would cause harm if administered to humans ^[3].

Immunogenicity is an immune reaction to the material. Aggregation is peptide molecules clumping into structures the body reads as foreign; peptide-related impurities are the truncated and modified sequences synthesis leaves behind. Purity testing addresses the second of those. Nothing on a standard purity certificate addresses pyrogen load, because bacterial endotoxins are cell wall fragments that survive processes which kill the organisms that made them and require an assay of their own ^[5].

So when a listing offers a purity figure and nothing else, it is answering one of the three questions FDA implicitly asked, and quietly leaving the other two unaddressed.

What the listing should cost

Semax 10 mg is listed at $59.99, or $30.00 with the code PEPTIDEDECK, which is $3.00 per milligram on the label weight. Quantity tiers of 3%, 5% and 10% apply at 3, 5 and 10 vials against the list price, as a separate mechanism from the code, and free shipping starts at $250. We do not publish a combined figure for a tiered cart with the code applied, because whether they stack is not documented anywhere we can verify. The full breakdown, including what the assayed 11.23 mg does to the real per-milligram number, is on the semax price page.

Questions buyers ask about these listings

Is a semax for sale listing legal if it does not mention a prescription?

Selling it as a research chemical is lawful, and a listing that says so is being accurate rather than evasive. A listing that instead describes human dosing or clinical benefits has stepped outside what any US seller of this compound can lawfully claim.

What is the single most important field on a listing?

The lot number, and whether the linked certificate names it. Every other quality claim is downstream of the document describing your batch rather than someone else's.

Does 99.886% purity make the other tests unnecessary?

No. Purity is the proportion of the powder that is the intended sequence. It cannot see pyrogen load and it cannot see microbial contamination. Those need separate assays, which is precisely why their presence on a certificate is worth noticing.

The vial is labelled 10 mg and the certificate says 11.23 mg. Which is right?

Both. The label is a nominal quantity and the certificate reports what that batch actually assayed at. Overfill is normal in this market and publishing the measured figure is not, so the disclosure counts in the vendor's favour. It applies to that lot only.

Should the inconsistency in the endotoxin report put me off?

It is a reason to ask a question, not a reason to discard the result. The reported figure, the acceptance limit and the controls are all consistent with a passing quantitative LAL test. The mismatch is in how the method is described on the page.

Are nasal spray listings held to the same standard?

They should be held to a higher one, since a solution in a multi-use bottle raises sterility and concentration questions a dry powder does not. In practice they publish less. The vendor linked here sells the vial and not a spray.

Semax for sale is a phrase that gets you a thousand near-identical pages, and the differences between them are not on the pages at all. They are in whether a document exists, whether it names your lot, and whether it covers the tests that address the only risk anybody official has written down. Read the certificate before the price, and read past its first page.